US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Wag! Group Co

0.1509

+0.00251.68%

Post-market: 0.1450-0.0059-3.91%19:47 EDT

Volume:957.26K

Turnover:139.66K

Market Cap:7.66M

PE:-0.38

High:0.1540

Open:0.1498

Low:0.1359

Close:0.1484

Loading ...

Overview Company News Filings

Top Midday Decliners

MT Newswires Live

Wag! Group Co reports results for the quarter ended December 31 - Earnings Summary

Wag! Group 2025 Outlook: Expects Revenues Of $84M-$88M Vs. $75.30M Est., Sees Adjusted EBITDA Of $2M-$4M

Wag Group Q4 2024 GAAP EPS $(0.10) Misses $(0.05) Estimate, Sales $15.43M Miss $18.90M Estimate

Wag! Group Co: Q4 Loss per Share $0.10

THOMSON REUTERS

Wag! Group Q4 Revenue USD 15.4 Million

THOMSON REUTERS

Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value

THOMSON REUTERS

Press Release: Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value

Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure

Wag! Group Co expected to post a loss of 5 cents a share - Earnings Preview

Wag! To Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease

Loop Announces Senior Leadership Appointments and Changes

ACCESS Newswire

Press Release: Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones

CIBC Reaffirms Their Buy Rating on Pet Valu Holdings Ltd. (PET)

Pet Valu Holdings Ltd. (PET) Gets a Buy from Barclays

Voyager Therapeutics Reports Positive Trial Results From Alzheimer's Disease Treatment

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PET/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PET","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PET\",,,,,undefined,":{"symbol":"PET","market":"US","secType":"STK","nameCN":"Wag! Group Co","latestPrice":0.1509,"timestamp":1746820800000,"preClose":0.1484,"halted":0,"volume":957262,"hourTrading":{"tag":"盘后","latestPrice":0.145,"preClose":0.1509,"latestTime":"19:47 EDT","volume":25386,"amount":3789.2527,"timestamp":1746834459140},"delay":0,"floatShares":21951206,"shares":50733823,"eps":-0.392853,"marketStatus":"Closed","change":0.0025,"latestTime":"05-09 16:00:00 EDT","open":0.1498,"high":0.154,"low":0.1359,"amount":139657.97812791998,"amplitude":0.121968,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.392853,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1484,"preHourTrading":{"tag":"盘前","latestPrice":0.155,"preClose":0.1484,"latestTime":"09:27 EDT","volume":7248,"amount":1090.78833984,"timestamp":1746797241987},"postHourTrading":{"tag":"盘后","latestPrice":0.145,"preClose":0.1509,"latestTime":"19:47 EDT","volume":25386,"amount":3789.2527,"timestamp":1746834459140},"volumeRatio":0.435826},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PET\",,,,,undefined,":{"symbol":"PET","floatShares":21951206,"roa":"-16.97%","roe":"-3036.82%","lyrEps":-0.392853,"volumeRatio":0.435826,"shares":50733823,"dividePrice":0,"high":0.154,"amplitude":0.121968,"preClose":0.1484,"low":0.1359,"week52Low":0.075,"pbRate":"-15.66","psRate":"0.11","week52High":2.47,"institutionHeld":0,"latestPrice":0.1509,"eps":-0.392853,"divideRate":0,"volume":957262,"delay":0,"ttmEps":-0.392853,"open":0.1498,"prevYearClose":0.2383,"prevWeekClose":0.1636,"prevMonthClose":0.145,"prevQuarterClose":0.1531,"fiveDayClose":0.1636,"twentyDayClose":0.1273,"sixtyDayClose":0.3394,"earningDate":1746979200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PET\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522752706","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2522752706","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522752706?lang=en_us&edition=fundamental","pubTime":"2025-03-25 02:37","pubTimestamp":1742841460,"startTime":"0","endTime":"0","summary":"23andMe  filed for Chapter 11 bankruptcy protection to help facilitate a potential sale, while Anne Wojcicki resigned as chief executive, less than a month after she attempted to acquire the genetic testing firm.Shares slumped 57%, with intraday trading volume of over 5.5 million against a daily average of about 292,000.TransCode Therapeutics  said Sunday it agreed to sell 10.25 million shares and warrants to buy up to 10.25 million shares at $0.98 per share and warrant to raise some $10 million.Shares sank 38% as intraday trading volume rose to over 15.5 million from a daily average of about 6.36 million.Wag!Group  said Monday its board is advancing a review of \"strategic alternatives to identify opportunities to maximize value for shareholders, including potential investments, strategic partnerships, sale, merger, or other strategic transactions involving the company or its assets.\"Shares slid 22% as intraday trading volume rose to over 1.3 million from a daily average of about 665,0","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PET.AU","BK4139","BK4121","BK4539","BK4196","BK7047","PET","ME","BK4192","MEHCQ","RNAZ"],"gpt_icon":1},{"id":"2521972438","title":"Wag! Group Co reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2521972438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521972438?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:31","pubTimestamp":1742823111,"startTime":"0","endTime":"0","summary":"Group Co reports results for the quarter ended December 31 - Earnings SummaryWag!Group Co PET.OQ reported a quarterly adjusted loss of 9 cents per share for the quarter ended December 31, identical to the same quarter last year.  The mean expectation of two analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -8 cents to -2 cents per share.Revenue fell 28.8% to $15.43 million from a year ago; analysts expected $18.90 million. Wag!Group Co's reported EPS for the quarter was a loss of 10 cents.The company reported a quarterly loss of $4.81 million.Wag!","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL5N3Q713V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PET"],"gpt_icon":0},{"id":"2521174698","title":"Wag! Group 2025 Outlook: Expects Revenues Of $84M-$88M Vs. $75.30M Est., Sees Adjusted EBITDA Of $2M-$4M","url":"https://stock-news.laohu8.com/highlight/detail?id=2521174698","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521174698?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:04","pubTimestamp":1742814276,"startTime":"0","endTime":"0","summary":"GuidanceFor the full year 2025, we expect:Revenues in the range of $84 million to $88 million.Adjusted EBITDA1 in the range of $2.0 million to $4.0 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44454636/wag-group-2025-outlook-expects-revenues-of-84m-88m-vs-75-30m-est-sees-adjusted-ebitda-of-2m-4m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PET"],"gpt_icon":0},{"id":"2521745081","title":"Wag Group Q4 2024 GAAP EPS $(0.10) Misses $(0.05) Estimate, Sales $15.43M Miss $18.90M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745081","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745081?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:01","pubTimestamp":1742814114,"startTime":"0","endTime":"0","summary":"Wag Group (NASDAQ:PET) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.05) by 100 percent. This is a 11.11 percent decrease over losses of $(0.09) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44454598/wag-group-q4-2024-gaap-eps-0-10-misses-0-05-estimate-sales-15-43m-miss-18-90m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PET"],"gpt_icon":0},{"id":"2521774682","title":"Wag! Group Co: Q4 Loss per Share $0.10","url":"https://stock-news.laohu8.com/highlight/detail?id=2521774682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521774682?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX5AB337:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","PET"],"gpt_icon":0},{"id":"2521456897","title":"Wag! Group Q4 Revenue USD 15.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2521456897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521456897?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nPLX5AB337:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PET","BK4192"],"gpt_icon":0},{"id":"2521745693","title":"Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745693","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745693?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA2GVWYF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PET","BK4192"],"gpt_icon":0},{"id":"2521745459","title":"Press Release: Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745459","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745459?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value. \"; Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced financial results for the fourth quarter and full year ended December 31, 2024. The Company also announced that its Board of Directors  is advancing its review of strategic alternatives to identify opportunities to maximize value for shareholders, including potential investments, strategic partnerships, sale, merger, or other strategic transactions involving the Company or its assets.\"Our Board and management team continues to believe in the strength of our business, the effectiveness of our strategic plan, and our ability to execute on our strategy to drive value for shareholders,\" said Garrett Smallwood, CEO and Chairman of Wag!. \"We remain focused on strengthening our balance sheet and reducing our deb","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["Z4D.SI","PET","BK6088","BK4192","BK6046"],"gpt_icon":0},{"id":"2521586307","title":"Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2521586307","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521586307?lang=en_us&edition=fundamental","pubTime":"2025-03-24 10:33","pubTimestamp":1742783582,"startTime":"0","endTime":"0","summary":"The first of two of Opthea’s eye disease trials has failed to meet its primary endpoints. Hitiq has signed a deal with a key Australian Rules amateur league to supply its smart concussion mouthguards. Telix’s FDA news is good for prostate cancer patients in remote areas","market":"nz","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/03/image-3-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/03/image-3-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/health-check-optheas-solvency-is-in-question-following-monumental-phase-iii-eye-disease-trial-failure/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4585","III","BK4084","BK4533","PET","BK4217","OPT","BK4192","PSA","BK4134","BK4139","BK4588"],"gpt_icon":0},{"id":"2521289203","title":"Wag! Group Co  expected to post a loss of 5 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521289203","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521289203?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:04","pubTimestamp":1742562245,"startTime":"0","endTime":"0","summary":"Group Co  expected to post a loss of5cents a share - Earnings Preview Wag!Group Co PET.OQ PET.O is expected to show a fall in quarterly revenue when it reports  results on March 24 for the period ending December 31 2024The San Francisco California-based  company is expected to report a 12.8% decrease in revenue to $18.9 million from $21.67 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.LSEG's mean analyst estimate for Wag!Group Co is for a loss of 5 cents per share. The one available analyst rating on the shares is \"hold\".  The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Wag!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q415S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PET"],"gpt_icon":0},{"id":"2520934434","title":"Wag! To Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520934434","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520934434?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:05","pubTimestamp":1742328300,"startTime":"0","endTime":"0","summary":"Group Co., (the “Company” or “Wag!”, Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modernU.S.pet household, today announced that it will report fourth quarter and full year 2024 financial results before market open on Monday, March 24, 2025. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results.Group Co.strives to be the number one platform to solve the service, product, and wellness needs of the modernU.S.pet household. Wag!pioneered on-demand dog walking in 2015 with the Wag!app, which offers access to 5-star dog walking, sitting, and one-on-one training from a community of over 500,000 Pet Caregivers nationwide. In addition,Wag!Group Co.operatesPetted, one of the nation’s largest pet insurance comparison marketplaces;Dog Food Advisor, one of the most visited and trusted pet food review platforms;WoofWoofTV, a multi-media company bringing delightful pet content to over 18","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wag-report-fourth-quarter-full-200500285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PET","BK4192","PETWW"],"gpt_icon":0},{"id":"2520842426","title":"Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America","url":"https://stock-news.laohu8.com/highlight/detail?id=2520842426","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520842426?lang=en_us&edition=fundamental","pubTime":"2025-03-18 05:53","pubTimestamp":1742248380,"startTime":"0","endTime":"0","summary":"MELBOURNE,Australia andPORTO ALEGRE,Brazil, March 18, 2025  -- Telix Pharmaceuticals Limited  today announces that the Brazilian Health Regulatory Agency  has approved Illuccix  the Company’s lead prostate cancer imaging agent. Illuccix is the first and only PSMA-PET1 prostate cancer imaging agent to receive full regulatory approval in Brazil.Illuccix, after radiolabeling with 68Ga, is a radioactive diagnostic agent indicated for positron emission tomography  of prostate-specific membrane antigen  positive lesions in men with prostate cancer:. With suspected metastasis who are candidates for definitive initial therapy treatment, and. With suspected recurrence based on an elevated specific antigen  level in the serum.PSMA-PET is a diagnostic technology demonstrated to detect advanced prostate cancer. ANVISA becomes the latest regulatory body worldwide to approve Illuccix3, which is already commercially available in Australia, Canada, New Zealand and the United States, and has recently b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/illuccix-approved-prostate-cancer-imaging-215300352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["XJO.AU","BK4543","BK4084","BK7047","UK","TGA.AU","TLX.AU","BK4213","BK4588","TLX","ASX","BK4144","BK4233","BK4585","PSA","PET.AU","BK4528","XAO.AU","XKO.AU","DCP","BK4139","ASX.AU","TGA","BK7039","BK4217","PET","BK7067","BK4205","BK4526","BK4533","BK4141","BK4192","BK7001","SEC.AU","EEA"],"gpt_icon":0},{"id":"2519887682","title":"Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887682","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887682?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863600,"startTime":"0","endTime":"0","summary":"-- Landmark exclusive option and license deal with Takeda for ACI-24.060. with $100 million upfront and additional potential milestones of up to. about $2.1 billion plus royalties on sales upon commercialization. -- ACI-24.060 ABATE Phase 1b/2 trial showed encouraging interim safety and. tolerability data in Down syndrome  cohort; further interim results. in Alzheimer's disease  and DS expected in 2025. -- Enrollment progress in JNJ-2056  ReTain Phase 2b trial in. preclinical AD patients triggered second milestone payment of CHF 24.6. -- ACI-7104.056 VacSYn Phase 2 trial demonstrated positive interim safety. and immunogenicity results in Parkinson's disease ; further interim. \"The ability to innovate is key to our future success. Driven by our two drug discovery platforms, in 2024, we advanced multiple early-stage asse","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU0345769128.USD","BK4592","IE0009355771.USD","LU1244550577.SGD","BK4604","ACI","ACIU","03160","R","PD","BK4532","BK4581","IE00BSNM7G36.USD","LU0234570918.USD","LU0203345920.USD","CBD","SG9999002224.SGD","IE00B42XCP33.USD","PET","IE00B2B36J28.USD","BK4555","LU0114720955.EUR","LU2089984988.USD","JNJ","LU1032466523.USD","LU0234572021.USD","IE00B4R5TH58.HKD","AC","IE000M9KFDE8.USD","PSP","LU1059921491.USD","LU0912757837.SGD","LU2430703095.HKD","LU1778281490.HKD","LU1506573853.SGD","BK4007","LU0320765646.SGD","AAIC","LU1221951129.SGD","LU0640476718.USD","TM","LU0792757196.USD","IE00BVYPNV92.GBP","LU2505996509.AUD","IE00BDGV0183.EUR","LU1169589451.USD","ARIA","LU1244550494.USD","LU1162221912.USD"],"gpt_icon":0},{"id":"2518877129","title":"Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518877129","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518877129?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:01","pubTimestamp":1741723260,"startTime":"0","endTime":"0","summary":"- Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP study; IND filing anticipated in 2026 - - Anti-tau antibody VY7523 was well","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040977/36461/en/Voyager-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-and-Operating-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","CTA","CSF","PET"],"gpt_icon":0},{"id":"2518459727","title":"Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2518459727","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518459727?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:30","pubTimestamp":1741696200,"startTime":"0","endTime":"0","summary":"Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Chairman, Longeveron","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040564/0/en/Longeveron-Announces-Nature-Medicine-Publication-of-Results-of-Phase-2a-Clinical-Trial-Evaluating-Laromestrocel-Lomecel-B-in-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4575","BK4150","LGVN","MSC","ARIA","BK4218","BK4181","INN","PET","BK4192","BK4139"],"gpt_icon":0},{"id":"2517438301","title":"Loop Announces Senior Leadership Appointments and Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2517438301","media":"ACCESS Newswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517438301?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:00","pubTimestamp":1741352400,"startTime":"0","endTime":"0","summary":"MONTRAL, QUEBEC / ACCESS Newswire / March 7, 2025 / Loop Industries, Inc.  , a clean technology company dedicated to accelerating circular fashion by manufacturing 100% recycled polyethylene terephthalate  plastic and textile-to-textile polyester fiber, today announced the following senior leadership changes as it transitions to the next phase of its strategic development with the commercialization of its technology.Giovanni Catino, Vice President of Sales, is appointed Chief Revenue Officer, reflecting his leadership role in developing and implementing Loop's sales strategy with global apparel and food and beverage customers. Giovanni will play the lead role in building out our global supply chains, including the addition of polyester fiber as a product offering through partnerships with spinning companies. Giovanni will also sit on the board of the India JV with Ester Industries.Daniel Solomita, Founder and CEO of Loop, commented \"I am excited with the development of Adel and Giovann","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/loop-announces-senior-leadership-appointments-130000046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PET","BK4090","BK4192","LOOP"],"gpt_icon":0},{"id":"2517210118","title":"Press Release: Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2517210118","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517210118?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:05","pubTimestamp":1741295100,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones. - Topline data from PIPE-791 Phase 1b positron emission tomography  trial expected in the second quarter of 2025. - Topline data from PIPE-307 Phase 2 VISTA trial for the treatment of relapsing-remitting multiple sclerosis  anticipated in the second half of 2025. Contineum Therapeutics, Inc.  , a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology  indications, today reported its fourth-quarter 2024 financial results and affirmed its key clinical development milestones.\"2025 is shaping up to be a pivotal year, as we have several important clinical data readouts and trial initiations on the horizon,\" said Carmine Stengone, CEO, Contineum Therapeutics. \"We expect to be sponsoring up to six clinical trials during the course of the year, with key topline data from our PIPE-791 Phase 1b posi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0792757196.USD","LU2505996681.GBP","LU0114720955.EUR","LU2129689431.USD","BK4532","LU1244550221.USD","IE00BVYPNV92.GBP","LU0640476718.USD","IE0034235303.USD","IE0002141913.USD","IE00B7SZLL34.SGD","BK4504","PET","LU1162221912.USD","SG9999001440.SGD","BK4192","LU1066053197.SGD","LU1196500208.SGD","LU0345769631.USD","BK4559","IE00BVYPNW00.USD","IE00BSNM7G36.USD","LU2129689514.USD","LU2430703095.HKD","LU1244550494.USD","IE0009355771.USD","LU1732800096.USD","LU2592432038.USD","LU2129689605.HKD","IE00BFTCPJ56.SGD","BK4585","BK4007","JNJ","LU0234570918.USD","LU0345769128.USD","LU1061106388.HKD","LU1430594728.SGD","LU1244550577.SGD","LU0320765646.SGD","LENZ","LU0234572021.USD","LU0345770993.USD","CTNM","LU1267930813.SGD","LU0203347892.USD","LU1778281490.HKD","LU1914381329.SGD","IE000M9KFDE8.USD","LU1261432733.SGD","BK4550"],"gpt_icon":0},{"id":"2517894532","title":"CIBC Reaffirms Their Buy Rating on Pet Valu Holdings Ltd. (PET)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517894532","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517894532?lang=en_us&edition=fundamental","pubTime":"2025-03-05 23:07","pubTimestamp":1741187247,"startTime":"0","endTime":"0","summary":"CIBC analyst Mark Petrie maintained a Buy rating on Pet Valu Holdings Ltd. (PET – Research Report) today and set a price target of C$33.00. The com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cibc-reaffirms-their-buy-rating-on-pet-valu-holdings-ltd-pet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cibc-reaffirms-their-buy-rating-on-pet-valu-holdings-ltd-pet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PET"],"gpt_icon":0},{"id":"2517917459","title":"Pet Valu Holdings Ltd. (PET) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2517917459","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517917459?lang=en_us&edition=fundamental","pubTime":"2025-03-05 17:42","pubTimestamp":1741167771,"startTime":"0","endTime":"0","summary":"Barclays analyst Adrienne Yih maintained a Buy rating on Pet Valu Holdings Ltd. (PET – Research Report) today and set a price target of C$32.00. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pet-valu-holdings-ltd-pet-gets-a-buy-from-barclays-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pet-valu-holdings-ltd-pet-gets-a-buy-from-barclays-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PET","BK4192"],"gpt_icon":0},{"id":"2516657210","title":"Voyager Therapeutics Reports Positive Trial Results From Alzheimer's Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2516657210","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516657210?lang=en_us&edition=fundamental","pubTime":"2025-03-04 03:27","pubTimestamp":1741030053,"startTime":"0","endTime":"0","summary":"Voyager Therapeutics  reported positive results Monday from the single ascending dose trial of its investigational antibody VY7523, developed to selectively inhibit the spread of pathological tau in Alzheimer's disease.Data from the trial demonstrated the safety, tolerability, and dose-proportional pharmacokinetics of single intravenous doses in 48 healthy volunteers, the company said.The drug was well tolerated across all six ascending dose cohorts, meeting the primary objective of the trial, with no serious adverse events, severe adverse events, or infusion reactions reported.Voyager said it has initiated a multiple ascending dose trial of the drug in patients with early Alzheimer's disease, which is expected to generate initial tau positron emission tomography  imaging data in H2 2026.Voyager shares were down nearly 3% in recent trading.Price: 3.97, Change: -0.11, Percent Change: -2.70","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7047","PET.AU","BK4139","BK4192","PET","VYGR"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":116,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PET\",params:#limit:5,,,undefined,":[{"date":"2025-05-12","symbol":"PET","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1747036800000,"name":null,"time":"Pre-Market","dateTimestamp":1747022400000,"actualEps":null},{"market":"US","date":"2025-03-24","symbol":"PET","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2024-11-13","symbol":"PET","fiscalQuarterEnding":"2024/09","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2024-08-07","symbol":"PET","fiscalQuarterEnding":"2024/06","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.06},{"date":"2024-07-10","symbol":"PET","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1720598400000,"name":null,"time":"Pre-Market","dateTimestamp":1720584000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PET\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PET\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1731643200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PET\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PET","date":"2025-05-08","current":-0.440975,"percent":0.977247,"low":-51.918761,"twenty":-24.564075,"median":-4.45403,"eighty":-1.829238,"high":-0.269148,"avg":-10.087612,"sd":10.911327,"marketCap":7747054},"quantilePoints":[{"date":"2021-10-01","current":-7.916755,"twenty":-7.916755,"median":-7.908627,"eighty":-7.901458,"marketCap":149143750},{"date":"2021-10-08","current":-7.941139,"twenty":-7.942895,"median":-7.928947,"eighty":-7.908627,"marketCap":149603125},{"date":"2021-10-15","current":-7.900499,"twenty":-7.941172,"median":-7.916755,"eighty":-7.900499,"marketCap":148837500},{"date":"2021-10-22","current":-7.908627,"twenty":-7.941139,"median":-7.908627,"eighty":-7.900499,"marketCap":148990625},{"date":"2021-10-29","current":-7.908627,"twenty":-7.934637,"median":-7.908627,"eighty":-7.900499,"marketCap":148990625},{"date":"2021-11-05","current":-7.941139,"twenty":-7.941139,"median":-7.916755,"eighty":-7.900499,"marketCap":149603125},{"date":"2021-11-12","current":-7.949267,"twenty":-7.941139,"median":-7.924883,"eighty":-7.907001,"marketCap":149756250},{"date":"2021-11-19","current":-7.965524,"twenty":-7.949267,"median":-7.933011,"eighty":-7.908627,"marketCap":150062500},{"date":"2021-11-26","current":-8.185579,"twenty":-7.949267,"median":-7.933011,"eighty":-7.908627,"marketCap":154208125},{"date":"2021-12-03","current":-8.143943,"twenty":-7.965524,"median":-7.941139,"eighty":-7.908627,"marketCap":153423750},{"date":"2021-12-10","current":-8.110635,"twenty":-8.123958,"median":-7.941139,"eighty":-7.908627,"marketCap":152796250},{"date":"2021-12-17","current":-8.111634,"twenty":-8.143943,"median":-7.941139,"eighty":-7.908627,"marketCap":152815075},{"date":"2021-12-23","current":-8.135616,"twenty":-8.143943,"median":-7.949267,"eighty":-7.908627,"marketCap":153266875},{"date":"2021-12-31","current":-8.143943,"twenty":-8.143943,"median":-7.949267,"eighty":-7.911878,"marketCap":153423750},{"date":"2022-01-07","current":-25.77251,"twenty":-8.143943,"median":-7.957396,"eighty":-7.916755,"marketCap":153423750},{"date":"2022-01-14","current":-25.746157,"twenty":-8.168925,"median":-7.965524,"eighty":-7.916755,"marketCap":153266875},{"date":"2022-01-21","current":-25.746157,"twenty":-8.185579,"median":-7.977716,"eighty":-7.918381,"marketCap":153266875},{"date":"2022-01-28","current":-25.746157,"twenty":-25.693453,"median":-8.111634,"eighty":-7.924883,"marketCap":153266875},{"date":"2022-02-04","current":-25.825214,"twenty":-25.746157,"median":-8.115298,"eighty":-7.926509,"marketCap":153737500},{"date":"2022-02-11","current":-25.956975,"twenty":-25.746157,"median":-8.135616,"eighty":-7.933011,"marketCap":154521875},{"date":"2022-02-18","current":-25.904271,"twenty":-25.746157,"median":-8.143943,"eighty":-7.933011,"marketCap":154208125},{"date":"2022-02-25","current":-25.851566,"twenty":-25.77251,"median":-8.143943,"eighty":-7.933011,"marketCap":153894375},{"date":"2022-03-04","current":-25.930623,"twenty":-25.77251,"median":-8.143943,"eighty":-7.933011,"marketCap":154365000},{"date":"2022-03-11","current":-25.956975,"twenty":-25.825214,"median":-8.143943,"eighty":-7.941139,"marketCap":154521875},{"date":"2022-03-18","current":-26.115089,"twenty":-25.825214,"median":-8.160598,"eighty":-7.941139,"marketCap":155463125},{"date":"2022-03-25","current":-26.036032,"twenty":-25.851566,"median":-8.177252,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-01","current":-26.036032,"twenty":-25.877919,"median":-8.185579,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-08","current":-26.036032,"twenty":-25.904271,"median":-16.939516,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-14","current":-26.220498,"twenty":-25.956975,"median":-25.700041,"eighty":-7.941139,"marketCap":156090625},{"date":"2022-04-22","current":-26.036032,"twenty":-25.956975,"median":-25.746157,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-29","current":-26.088737,"twenty":-26.00968,"median":-25.746157,"eighty":-7.941269,"marketCap":155306250},{"date":"2022-05-06","current":-26.036032,"twenty":-26.01495,"median":-25.746157,"eighty":-7.947674,"marketCap":154992500},{"date":"2022-05-13","current":-24.509388,"twenty":-26.01495,"median":-25.746157,"eighty":-7.949267,"marketCap":154678750},{"date":"2022-05-20","current":-24.534246,"twenty":-26.00968,"median":-25.746157,"eighty":-7.949267,"marketCap":154835625},{"date":"2022-05-27","current":-24.68339,"twenty":-26.00968,"median":-25.719805,"eighty":-7.949267,"marketCap":155776875},{"date":"2022-06-03","current":-24.68339,"twenty":-26.00968,"median":-25.693453,"eighty":-7.949267,"marketCap":155776875},{"date":"2022-06-10","current":-24.583961,"twenty":-26.00968,"median":-24.68339,"eighty":-7.954144,"marketCap":155149375},{"date":"2022-06-17","current":-24.608818,"twenty":-26.00968,"median":-24.68339,"eighty":-7.957396,"marketCap":155306250},{"date":"2022-06-24","current":-24.708248,"twenty":-25.988598,"median":-24.68339,"eighty":-7.960647,"marketCap":155933750},{"date":"2022-07-01","current":-24.608818,"twenty":-25.956975,"median":-24.658533,"eighty":-7.965524,"marketCap":155306250},{"date":"2022-07-08","current":-24.733105,"twenty":-25.956975,"median":-24.658533,"eighty":-7.96715,"marketCap":156090625},{"date":"2022-07-15","current":-24.757962,"twenty":-25.956975,"median":-24.68339,"eighty":-7.975278,"marketCap":156247500},{"date":"2022-07-22","current":-24.807677,"twenty":-25.956975,"median":-24.68339,"eighty":-8.007551,"marketCap":156561250},{"date":"2022-07-29","current":-25.105966,"twenty":-25.956975,"median":-24.68339,"eighty":-8.110835,"marketCap":158443750},{"date":"2022-08-05","current":-19.587625,"twenty":-25.956975,"median":-24.68339,"eighty":-8.111634,"marketCap":123617500},{"date":"2022-08-12","current":-46.571248,"twenty":-25.956975,"median":-24.68339,"eighty":-8.111634,"marketCap":293911149},{"date":"2022-08-19","current":-31.187311,"twenty":-26.00968,"median":-24.68339,"eighty":-8.1131,"marketCap":196823120},{"date":"2022-08-26","current":-29.685032,"twenty":-26.00968,"median":-24.708248,"eighty":-8.118962,"marketCap":187342238},{"date":"2022-09-02","current":-34.550721,"twenty":-26.036032,"median":-24.733105,"eighty":-8.122293,"marketCap":159278826},{"date":"2022-09-09","current":-42.365766,"twenty":-26.036032,"median":-24.757962,"eighty":-8.135616,"marketCap":195306179},{"date":"2022-09-16","current":-44.175565,"twenty":-26.036032,"median":-24.78282,"eighty":-8.135616,"marketCap":203649356},{"date":"2022-09-23","current":-20.154587,"twenty":-26.036032,"median":-24.78282,"eighty":-8.143943,"marketCap":92912648},{"date":"2022-09-30","current":-16.864043,"twenty":-26.036032,"median":-24.745534,"eighty":-8.143943,"marketCap":77743236},{"date":"2022-10-07","current":-20.812696,"twenty":-26.036032,"median":-24.733105,"eighty":-8.143943,"marketCap":95946530},{"date":"2022-10-14","current":-24.020978,"twenty":-26.036032,"median":-24.708248,"eighty":-8.143943,"marketCap":110736707},{"date":"2022-10-21","current":-32.45159,"twenty":-26.036032,"median":-24.733105,"eighty":-8.143943,"marketCap":149601831},{"date":"2022-10-28","current":-34.873351,"twenty":-26.036032,"median":-24.745534,"eighty":-8.143943,"marketCap":160766146},{"date":"2022-11-04","current":-27.317458,"twenty":-26.115089,"median":-24.78282,"eighty":-8.143943,"marketCap":125933481},{"date":"2022-11-11","current":-2.304056,"twenty":-26.115089,"median":-24.78282,"eighty":-8.143943,"marketCap":108509519},{"date":"2022-11-18","current":-2.038504,"twenty":-26.115089,"median":-24.757962,"eighty":-8.143943,"marketCap":96003337},{"date":"2022-11-25","current":-1.9604,"twenty":-26.115089,"median":-24.733105,"eighty":-8.132285,"marketCap":92325048},{"date":"2022-12-02","current":-1.991642,"twenty":-26.094007,"median":-24.708248,"eighty":-8.111634,"marketCap":93796364},{"date":"2022-12-09","current":-1.62846,"twenty":-26.046573,"median":-24.68339,"eighty":-7.972026,"marketCap":76692321},{"date":"2022-12-16","current":-1.679227,"twenty":-26.036032,"median":-24.68339,"eighty":-7.95577,"marketCap":79083209},{"date":"2022-12-23","current":-2.436832,"twenty":-26.036032,"median":-24.658533,"eighty":-7.949267,"marketCap":114762610},{"date":"2022-12-30","current":-2.405591,"twenty":-26.036032,"median":-24.658533,"eighty":-7.941139,"marketCap":113291295},{"date":"2023-01-06","current":-2.069667,"twenty":-26.036032,"median":-24.633675,"eighty":-7.941139,"marketCap":97470974},{"date":"2023-01-13","current":-2.218142,"twenty":-26.036032,"median":-24.621246,"eighty":-7.933011,"marketCap":104463401},{"date":"2023-01-20","current":-2.17128,"twenty":-26.036032,"median":-24.608818,"eighty":-7.926509,"marketCap":102256428},{"date":"2023-01-27","current":-2.530556,"twenty":-26.036032,"median":-24.608818,"eighty":-7.916755,"marketCap":119176557},{"date":"2023-02-03","current":-2.155659,"twenty":-26.036032,"median":-24.608818,"eighty":-7.908627,"marketCap":101520770},{"date":"2023-02-10","current":-1.851055,"twenty":-26.036032,"median":-24.608818,"eighty":-7.902125,"marketCap":87175444},{"date":"2023-02-17","current":-1.874486,"twenty":-26.036032,"median":-24.571532,"eighty":-7.893997,"marketCap":88278931},{"date":"2023-02-24","current":-2.245322,"twenty":-26.036032,"median":-24.559103,"eighty":-2.530556,"marketCap":86595328},{"date":"2023-03-03","current":-2.245322,"twenty":-26.036032,"median":-24.534246,"eighty":-2.452453,"marketCap":86595328},{"date":"2023-03-10","current":-1.614721,"twenty":-26.036032,"median":-24.534246,"eighty":-2.413401,"marketCap":62274938},{"date":"2023-03-17","current":-1.94913,"twenty":-26.036032,"median":-24.534246,"eighty":-2.38997,"marketCap":75172115},{"date":"2023-03-24","current":-2.197549,"twenty":-26.036032,"median":-24.509388,"eighty":-2.340867,"marketCap":84752874},{"date":"2023-03-31","current":-2.140222,"twenty":-26.036032,"median":-24.020978,"eighty":-2.293095,"marketCap":82541930},{"date":"2023-04-06","current":-2.111558,"twenty":-26.036032,"median":-23.445132,"eighty":-2.245322,"marketCap":81436457},{"date":"2023-04-14","current":-2.159331,"twenty":-26.036032,"median":-22.561,"eighty":-2.225952,"marketCap":83278911},{"date":"2023-04-21","current":-2.203009,"twenty":-26.01495,"median":-21.964387,"eighty":-2.217056,"marketCap":84963432},{"date":"2023-04-28","current":-2.270943,"twenty":-26.00968,"median":-20.697308,"eighty":-2.210332,"marketCap":87583450},{"date":"2023-05-05","current":-2.021661,"twenty":-26.00968,"median":-19.99006,"eighty":-2.209686,"marketCap":77969386},{"date":"2023-05-12","current":-2.248784,"twenty":-26.00968,"median":-19.907797,"eighty":-2.209686,"marketCap":89960352},{"date":"2023-05-19","current":-2.248784,"twenty":-26.00968,"median":-19.587625,"eighty":-2.209686,"marketCap":89960352},{"date":"2023-05-26","current":-1.874257,"twenty":-26.00968,"median":-19.301764,"eighty":-2.197549,"marketCap":74977784},{"date":"2023-06-02","current":-2.174138,"twenty":-25.978057,"median":-18.097997,"eighty":-2.197549,"marketCap":86974229},{"date":"2023-06-09","current":-2.061683,"twenty":-25.956975,"median":-16.864043,"eighty":-2.186237,"marketCap":82475562},{"date":"2023-06-16","current":-2.127282,"twenty":-25.956975,"median":-8.185579,"eighty":-2.180933,"marketCap":85099784},{"date":"2023-06-23","current":-2.04294,"twenty":-25.956975,"median":-8.185579,"eighty":-2.17128,"marketCap":81725784},{"date":"2023-06-29","current":-1.958599,"twenty":-25.956975,"median":-8.185579,"eighty":-2.164767,"marketCap":78351784},{"date":"2023-07-07","current":-1.883628,"twenty":-25.956975,"median":-8.168925,"eighty":-2.16347,"marketCap":75352672},{"date":"2023-07-14","current":-1.893,"twenty":-25.956975,"median":-8.148107,"eighty":-2.155659,"marketCap":75727561},{"date":"2023-07-21","current":-2.04294,"twenty":-25.956975,"median":-8.143943,"eighty":-2.147849,"marketCap":81725784},{"date":"2023-07-28","current":-2.108539,"twenty":-25.956975,"median":-8.143943,"eighty":-2.139508,"marketCap":84350007},{"date":"2023-08-04","current":-2.267851,"twenty":-25.941164,"median":-8.143943,"eighty":-2.138794,"marketCap":90723118},{"date":"2023-08-11","current":-2.32208,"twenty":-25.920074,"median":-8.135616,"eighty":-2.137501,"marketCap":99345563},{"date":"2023-08-18","current":-2.075795,"twenty":-25.907779,"median":-8.118962,"eighty":-2.137501,"marketCap":88808739},{"date":"2023-08-25","current":-2.053134,"twenty":-25.904271,"median":-8.111634,"eighty":-2.127997,"marketCap":87839211},{"date":"2023-09-01","current":-1.840115,"twenty":-25.904271,"median":-8.046207,"eighty":-2.121113,"marketCap":78725651},{"date":"2023-09-08","current":-1.903567,"twenty":-25.903322,"median":-7.973652,"eighty":-2.112829,"marketCap":81440328},{"date":"2023-09-15","current":-1.758534,"twenty":-25.899527,"median":-7.965524,"eighty":-2.108539,"marketCap":75235351},{"date":"2023-09-22","current":-1.695082,"twenty":-25.877919,"median":-7.953331,"eighty":-2.093176,"marketCap":72520673},{"date":"2023-09-29","current":-1.740405,"twenty":-25.851566,"median":-7.949267,"eighty":-2.080425,"marketCap":74459729},{"date":"2023-10-06","current":-1.704146,"twenty":-25.851566,"median":-7.945284,"eighty":-2.069745,"marketCap":72908484},{"date":"2023-10-13","current":-1.676952,"twenty":-25.851566,"median":-7.941139,"eighty":-2.061683,"marketCap":71745051},{"date":"2023-10-20","current":-1.60933,"twenty":-25.851566,"median":-7.941139,"eighty":-2.052312,"marketCap":68851980},{"date":"2023-10-27","current":-1.568177,"twenty":-25.851566,"median":-7.941139,"eighty":-2.045204,"marketCap":67091318},{"date":"2023-11-03","current":-1.560563,"twenty":-25.851566,"median":-7.933011,"eighty":-2.038504,"marketCap":66765557},{"date":"2023-11-10","current":-16.478139,"twenty":-25.851566,"median":-7.933011,"eighty":-2.036475,"marketCap":66703507},{"date":"2023-11-17","current":-17.055401,"twenty":-25.841025,"median":-7.941139,"eighty":-2.038504,"marketCap":69040264},{"date":"2023-11-24","current":-17.063157,"twenty":-25.825214,"median":-7.941139,"eighty":-2.038504,"marketCap":69071661},{"date":"2023-12-01","current":-17.063157,"twenty":-25.825214,"median":-7.941139,"eighty":-2.039391,"marketCap":69071661},{"date":"2023-12-08","current":-16.966208,"twenty":-25.825214,"median":-7.949267,"eighty":-2.04294,"marketCap":68679208},{"date":"2023-12-15","current":-16.869258,"twenty":-25.825214,"median":-7.949267,"eighty":-2.04294,"marketCap":68286755},{"date":"2023-12-22","current":-17.257057,"twenty":-25.819944,"median":-7.957396,"eighty":-2.044072,"marketCap":69856566},{"date":"2023-12-29","current":-16.966208,"twenty":-25.804132,"median":-7.96146,"eighty":-2.047469,"marketCap":68679208},{"date":"2024-01-05","current":-17.063157,"twenty":-25.798862,"median":-7.965524,"eighty":-2.050085,"marketCap":69071661},{"date":"2024-01-12","current":-16.384509,"twenty":-25.798862,"median":-8.046207,"eighty":-2.052312,"marketCap":66324492},{"date":"2024-01-19","current":-17.450956,"twenty":-25.793592,"median":-8.111634,"eighty":-2.052312,"marketCap":70641471},{"date":"2024-01-26","current":-19.293002,"twenty":-25.77251,"median":-8.118962,"eighty":-2.052476,"marketCap":78098071},{"date":"2024-02-02","current":-19.370562,"twenty":-25.77251,"median":-8.135616,"eighty":-2.054844,"marketCap":78412033},{"date":"2024-02-09","current":-17.935705,"twenty":-25.77251,"median":-8.143943,"eighty":-2.061683,"marketCap":72603734},{"date":"2024-02-16","current":-6.45394,"twenty":-25.77251,"median":-8.143943,"eighty":-2.06328,"marketCap":85947123},{"date":"2024-02-23","current":-5.95295,"twenty":-25.77251,"median":-8.139779,"eighty":-2.069667,"marketCap":79275429},{"date":"2024-03-01","current":-5.894009,"twenty":-25.77251,"median":-8.118962,"eighty":-2.069745,"marketCap":78490524},{"date":"2024-03-08","current":-6.33606,"twenty":-25.746157,"median":-8.111634,"eighty":-2.069745,"marketCap":84377313},{"date":"2024-03-15","current":-6.12977,"twenty":-25.746157,"median":-8.110635,"eighty":-2.075795,"marketCap":81630144},{"date":"2024-03-22","current":-5.894009,"twenty":-25.746157,"median":-7.969588,"eighty":-2.077556,"marketCap":78490524},{"date":"2024-03-28","current":-5.658249,"twenty":-25.746157,"median":-7.96146,"eighty":-2.077556,"marketCap":75350903},{"date":"2024-04-05","current":-6.089301,"twenty":-25.746157,"median":-7.949267,"eighty":-2.079851,"marketCap":81091218},{"date":"2024-04-12","current":-6.392251,"twenty":-25.746157,"median":-7.949267,"eighty":-2.080425,"marketCap":85125607},{"date":"2024-04-19","current":-6.301366,"twenty":-25.746157,"median":-7.941302,"eighty":-2.084378,"marketCap":83915291},{"date":"2024-04-26","current":-6.664906,"twenty":-25.746157,"median":-7.941139,"eighty":-2.091032,"marketCap":88756558},{"date":"2024-05-03","current":-6.831529,"twenty":-25.746157,"median":-7.941139,"eighty":-2.093031,"marketCap":90975471},{"date":"2024-05-10","current":-7.133641,"twenty":-25.746157,"median":-7.937075,"eighty":-2.09797,"marketCap":98237372},{"date":"2024-05-17","current":-5.947142,"twenty":-25.746157,"median":-7.933011,"eighty":-2.099168,"marketCap":81898096},{"date":"2024-05-24","current":-4.687403,"twenty":-25.735616,"median":-7.924883,"eighty":-2.106665,"marketCap":64550224},{"date":"2024-05-31","current":-4.572017,"twenty":-25.71717,"median":-7.916755,"eighty":-2.108539,"marketCap":62961251},{"date":"2024-06-07","current":-4.572017,"twenty":-25.698723,"median":-7.908627,"eighty":-2.108539,"marketCap":62961251},{"date":"2024-06-14","current":-4.513024,"twenty":-25.693453,"median":-7.908627,"eighty":-2.108642,"marketCap":62148847},{"date":"2024-06-21","current":-4.365539,"twenty":-25.580927,"median":-7.908627,"eighty":-2.109349,"marketCap":60117839},{"date":"2024-06-28","current":-4.92598,"twenty":-25.355875,"median":-7.908627,"eighty":-2.110454,"marketCap":67835670},{"date":"2024-07-05","current":-4.719502,"twenty":-25.12088,"median":-7.900499,"eighty":-2.114099,"marketCap":64992259},{"date":"2024-07-12","current":-4.45403,"twenty":-24.996593,"median":-7.900499,"eighty":-2.119192,"marketCap":61336444},{"date":"2024-07-15","current":-4.719502,"twenty":-24.941907,"median":-7.900499,"eighty":-2.119832,"marketCap":64992259},{"date":"2024-08-02","current":-3.480633,"twenty":-24.88722,"median":-7.896435,"eighty":-2.120473,"marketCap":47931791},{"date":"2024-08-09","current":-3.44267,"twenty":-24.832534,"median":-7.872782,"eighty":-2.121113,"marketCap":41838766},{"date":"2024-08-16","current":-3.734947,"twenty":-24.812648,"median":-6.984832,"eighty":-2.126048,"marketCap":45390806},{"date":"2024-08-23","current":-3.084343,"twenty":-24.807677,"median":-6.876972,"eighty":-2.127282,"marketCap":37484020},{"date":"2024-08-30","current":-3.413661,"twenty":-24.787791,"median":-6.869398,"eighty":-2.127282,"marketCap":41486221},{"date":"2024-09-06","current":-3.375508,"twenty":-24.78282,"median":-6.801234,"eighty":-2.127997,"marketCap":41022551},{"date":"2024-09-13","current":-2.972696,"twenty":-24.767905,"median":-6.725496,"eighty":-2.129789,"marketCap":36127177},{"date":"2024-09-20","current":-3.449806,"twenty":-24.757962,"median":-6.635604,"eighty":-2.134259,"marketCap":41925487},{"date":"2024-09-27","current":-3.545388,"twenty":-24.743048,"median":-6.543726,"eighty":-2.136653,"marketCap":43087101},{"date":"2024-10-04","current":-3.48595,"twenty":-24.733105,"median":-6.48341,"eighty":-2.137501,"marketCap":42364752},{"date":"2024-10-11","current":-3.353821,"twenty":-24.733105,"median":-6.45394,"eighty":-2.13936,"marketCap":40758992},{"date":"2024-10-18","current":-3.413661,"twenty":-24.718191,"median":-6.392251,"eighty":-2.140222,"marketCap":41486221},{"date":"2024-10-25","current":-3.226914,"twenty":-24.708248,"median":-6.361956,"eighty":-2.143518,"marketCap":39216680},{"date":"2024-10-31","current":-2.961451,"twenty":-24.708248,"median":-6.331661,"eighty":-2.146569,"marketCap":35990517},{"date":"2024-11-08","current":-2.552615,"twenty":-24.698305,"median":-6.303978,"eighty":-2.147849,"marketCap":31021931},{"date":"2024-11-15","current":-0.547386,"twenty":-24.68339,"median":-6.27712,"eighty":-2.146569,"marketCap":8878051},{"date":"2024-11-22","current":-0.606003,"twenty":-24.68339,"median":-6.22989,"eighty":-2.137218,"marketCap":9828767},{"date":"2024-11-29","current":-0.659113,"twenty":-24.68339,"median":-6.184448,"eighty":-2.128912,"marketCap":10690153},{"date":"2024-12-06","current":-0.685514,"twenty":-24.68339,"median":-6.12977,"eighty":-2.122347,"marketCap":11118357},{"date":"2024-12-13","current":-0.70639,"twenty":-24.678419,"median":-6.080065,"eighty":-2.109349,"marketCap":11456936},{"date":"2024-12-20","current":-0.621353,"twenty":-24.658533,"median":-6.04136,"eighty":-2.101042,"marketCap":10077722},{"date":"2024-12-27","current":-0.728186,"twenty":-24.658533,"median":-6.035031,"eighty":-2.092449,"marketCap":11810453},{"date":"2025-01-03","current":-0.874929,"twenty":-24.658533,"median":-6.01189,"eighty":-2.079851,"marketCap":14190469},{"date":"2025-01-10","current":-0.83195,"twenty":-24.658533,"median":-5.968121,"eighty":-2.073375,"marketCap":13493393},{"date":"2025-01-17","current":-0.801251,"twenty":-24.643618,"median":-5.93531,"eighty":-2.061683,"marketCap":12995482},{"date":"2025-01-24","current":-0.788664,"twenty":-24.633675,"median":-5.894009,"eighty":-2.052312,"marketCap":12791338},{"date":"2025-01-31","current":-0.791427,"twenty":-24.633675,"median":-5.894009,"eighty":-2.04294,"marketCap":12836150},{"date":"2025-02-07","current":-0.997726,"twenty":-24.623732,"median":-5.776129,"eighty":-2.038504,"marketCap":16182114},{"date":"2025-02-14","current":-1.099033,"twenty":-24.608818,"median":-5.658249,"eighty":-2.027617,"marketCap":17825220},{"date":"2025-02-21","current":-0.92282,"twenty":-24.608818,"median":-5.628779,"eighty":-2.021458,"marketCap":14967210},{"date":"2025-02-28","current":-0.775463,"twenty":-24.608818,"median":-5.099654,"eighty":-1.992156,"marketCap":12577236},{"date":"2025-03-07","current":-0.775156,"twenty":-24.608818,"median":-4.778496,"eighty":-1.977341,"marketCap":12572257},{"date":"2025-03-14","current":-0.75643,"twenty":-24.608818,"median":-4.719502,"eighty":-1.959028,"marketCap":12268531},{"date":"2025-03-21","current":-0.722967,"twenty":-24.608818,"median":-4.719502,"eighty":-1.953792,"marketCap":11725808},{"date":"2025-03-28","current":-0.540029,"twenty":-24.608818,"median":-4.704754,"eighty":-1.94913,"marketCap":9487224},{"date":"2025-04-04","current":-0.369934,"twenty":-24.608818,"median":-4.631011,"eighty":-1.92291,"marketCap":6499002},{"date":"2025-04-11","current":-0.367624,"twenty":-24.608818,"median":-4.601514,"eighty":-1.893,"marketCap":6458415},{"date":"2025-04-17","current":-0.343077,"twenty":-24.608818,"median":-4.572017,"eighty":-1.883628,"marketCap":6027178},{"date":"2025-04-25","current":-0.440398,"twenty":-24.608818,"median":-4.54252,"eighty":-1.867309,"marketCap":7736908},{"date":"2025-05-02","current":-0.423359,"twenty":-24.583961,"median":-4.45403,"eighty":-1.840115,"marketCap":7437578},{"date":"2025-05-08","current":-0.440975,"twenty":-24.564075,"median":-4.45403,"eighty":-1.829238,"marketCap":7747054}],"updateTime":1746846912377}}}